The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 21, 2022
Filed:
May. 18, 2017
Applicant:
Dermala Inc., San Diego, CA (US);
Inventors:
Lada Rasochova, Del Mar, CA (US);
Michelle Kem, San Diego, CA (US);
Assignee:
Dermala, Inc., San Diego, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/19 (2006.01); A61P 17/00 (2006.01); A61P 31/04 (2006.01); A61P 29/00 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/197 (2006.01); A61K 31/22 (2006.01); A61K 31/225 (2006.01); A61K 31/25 (2006.01); A61K 31/436 (2006.01); A61K 31/56 (2006.01); A61K 36/899 (2006.01); A61K 39/395 (2006.01); A61K 47/46 (2006.01); C07K 16/28 (2006.01); C07K 16/42 (2006.01); A61K 31/194 (2006.01); A61K 31/58 (2006.01); A61K 31/573 (2006.01); A61K 31/221 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/19 (2013.01); A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 31/194 (2013.01); A61K 31/197 (2013.01); A61K 31/22 (2013.01); A61K 31/221 (2013.01); A61K 31/225 (2013.01); A61K 31/25 (2013.01); A61K 31/436 (2013.01); A61K 31/56 (2013.01); A61K 31/573 (2013.01); A61K 31/58 (2013.01); A61K 36/899 (2013.01); A61K 39/3955 (2013.01); A61K 39/39566 (2013.01); A61K 45/06 (2013.01); A61K 47/46 (2013.01); A61P 17/00 (2018.01); A61P 29/00 (2018.01); A61P 31/04 (2018.01); C07K 16/2866 (2013.01); C07K 16/4291 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01);
Abstract
Disclosed are compositions, methods of treatment using the compositions and methods of preparing the compositions for the treatment of eczema. The compositions may include propionic acid and/or non-steroidal esters of propionic acid. The compositions may further include a corticosteroid, immunomodulator, antibiotic, antibody, colloidal oatmeal, conditioned media prepared by bacterial fermentation, short chain fatty acids, picolinic acid, or emollient. The method of treatment may include analysis of the skin microbiome.